Abstract
Hepatocellular carcinoma (HCC) is a serious cancer which ranked the fourth in cancer-related death worldwide. Hence, more accurate diagnostic models are urgently needed to aid the early HCC diagnosis under clinical scenarios and thus improve HCC treatment and survival. Several conventional methods have been used for discriminating HCC from cirrhosis tissues in patients without HCC (CwoHCC). However, the recognition successful rates are still far from satisfactory. In this study, we applied a computational approach that based on machine learning method to a set of microarray data generated from 1091 HCC samples and 242 CwoHCC samples. The within-sample relative expression orderings (REOs) method was used to extract numerical descriptors from gene expression profiles datasets. After removing the unrelated features by using maximum redundancy minimum relevance (mRMR) with incremental feature selection, we achieved “11-gene-pair” which could produce outstanding results. We further investigated the discriminate capability of the “11-gene-pair” for HCC recognition on several independent datasets. The wonderful results were obtained, demonstrating that the selected gene pairs can be signature for HCC. The proposed computational model can discriminate HCC and adjacent non-cancerous tissues from CwoHCC even for minimum biopsy specimens and inaccurately sampled specimens, which can be practical and effective for aiding the early HCC diagnosis at individual level.
Highlights
Liver cancer is the fourth leading cause of death in patients with malignant cancerous (Indhumathy et al, 2018; Villanueva, 2019)
Based on the new profiles, 11 gene pairs shown in Table 1 were picked out by using maximum redundancy minimum relevance (mRMR) with Support Vector Machine (SVM) and regarded as the diagnostic signature
Pathology is used as a gold standard for Hepatocellular carcinoma (HCC) diagnosis, the histological analysis of the HCC biopsy specimen is influenced by the sampling location and tissue amount
Summary
Liver cancer is the fourth leading cause of death in patients with malignant cancerous (Indhumathy et al, 2018; Villanueva, 2019). Hepatocellular carcinoma (HCC), which accounts for approximately 90% of all liver cancer cases, is frequently diagnosed at a late stage and has a poor prognosis. The early HCC diagnosis is significant to improve the prognosis and survival of patients (AsiaPacific Working Party on Prevention of Hepatocellular Carcinoma, 2010). Diagnosis of HCC is based on laboratory investigations and imaging techniques (El-Serag, 2011; Hartke et al, 2017). For HCC, especially for early HCC, current serum biomarkers and tools, such as α-fetoprotein (AFP) and imaging techniques, displayed poor diagnostic sensitivity and specificity (Sun et al, 2015). Liver biopsy is regarded as a good diagnostic choice in clinical practice only when
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.